Date: Mon, 22 Nov 1999 17:19:09 -0700

~~~ There's also a VERY good article in todays Wall Street Journal about Reich & former fraud of his, etc. they mentioned, too, that all their cases had been settled. i've heard well under $500 a woman, tops. if anyone can get the WSJ article for us it's very interesting. here's some others from their PR posters on alt.support.breast-implant~~~

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Nov. 22, 1999--Inamed Corp. (Nasdaq: IMDC) announced that earlier today it consummated a public offering of its shares, the pricing of which was announced last week. Underwriters exercised their over-allotment option in full.

Of the 3,450,000 shares of Inamed common stock that were sold, 2,950,000 were offered by Inamed, including 450,000 shares issued upon exercise of the underwriters' over-allotment option. The remaining 500,000 shares were offered by certain funds managed by Oracle Partners, L.P.

Inamed did not receive any of the proceeds from shares sold by the Oracle Partners funds. All of the net proceeds of the offering received by Inamed, totaling approximately $78,745,000 after underwriting discounts and estimated expenses, will be used to repay principal and pay accrued interest and any required fees to lenders under the company's bridge loan facility, arranged by U.S. Bancorp Libra. Lead lenders under the bridge loan facility are affiliates of Cerberus Capital Management, L.P.

The equity offering was made through an underwriting group composed of Hambrecht & Quist LLC, Bear, Stearns & Co. Inc. and CIBC World Markets Corp. A copy of the prospectus may be obtained from Hambrecht & Quist LLC, One Bush Street, San Francisco, Calif. 94104, 415/439-3000.

Inamed is a global surgical and medical device company engaged in the development, manufacturing and marketing of products for the plastic and reconstructive surgery, aesthetic medicine and obesity markets.

Inamed sells a variety of lifestyle products used to make people look younger and more attractive, including breast implants for cosmetic augmentation and collagen-based facial implants to correct facial wrinkles and to improve lip definition. Inamed also sells products that address women's health issues, including breast implants for reconstructive surgery following radical mastectomies, and devices that treat severe obesity and urinary incontinence.

Inamed Corp.

Ilan Reich/Michael Doty, 212/273-3430

Inamed Corp. Announces Pricing of Public Offering

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Nov. 17, 1999--Inamed Corp.(Nasdaq:IMDC) announced that its public offering of 3 million shares of common stock was priced yesterday at $29.00 per share, for gross proceeds of $87 million.

Of the 3 million shares, 2,500,000 were offered by Inamed. The remaining 500,000 shares were offered by certain funds managed by Oracle Partners L.P. Inamed will not receive any of the proceeds from shares sold by the Oracle Partners funds.

All of the net proceeds of the offering received by Inamed, totaling approximately $66,550,000 after underwriting discounts and estimated expenses, will be used to repay principal and pay accrued interest and any required fees to lenders under the company's bridge loan facility, arranged by U.S. Bancorp Libra.

The offering will be made through an underwriting group composed of Hambrecht & Quist LLC; Bear, Stearns & Co. Inc.; and CIBC World Markets Corp. Inamed has granted to the underwriters an over-allotment option for a period of 30 days to purchase an additional 450,000 shares at the public offering price.

A copy of the prospectus will be available from Hambrecht & Quist LLC, One Bush Street, San Francisco, Calif., 94104; phone 415/439-3000.

Inamed is a global surgical and medical device company engaged in the development, manufacturing and marketing of products for the plastic and reconstructive surgery, aesthetic medicine and obesity markets.

Inamed sells a variety of lifestyle products used to make people look younger and more attractive, including breast implants for cosmetic augmentation and collagen-based facial implants to correct facial wrinkles and to improve lip definition. Inamed also sells products that address women's health issues, including breast implants for reconstructive surgery following radical mastectomies, and devices that treat severe obesity and urinary incontinence.

NOTE: This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

Inamed Corp.

Ilan Reich/Michael Doty, 212/273-3430

KEYWORD: CALIFORNIA